Antidepressant and QT interval prolongation, how should we look at this issue? Focus on citalopram

Evaluation of the FDA Warning Against Prescribing Citalopram at Doses Exceeding 40 mg

(2013) Kara Zivin et al.   AMERICAN JOURNAL OF PSYCHIATRY

QT interval and antidepressant use: a cross sectional study of electronic health records

(2013) V. M. Castro et al.   BMJ-British Medical Journal

Citalopram, QTc Interval Prolongation, and Torsade de Pointes. How Should We Apply the Recent FDA Ruling?

(2012) W. Victor R. Vieweg et al.   AMERICAN JOURNAL OF MEDICINE

Antidepressant Use and Risk of Out-of-Hospital Cardiac Arrest: A Nationwide Case–Time–Control Study

(2012) P Weeke et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Toxicology and Overdose of Atypical Antipsychotics

(2012) Alicia B. Minns et al.   JOURNAL OF EMERGENCY MEDICINE

Exposure to Antidepressant Medications and Suicide Attempts in Adult Depressed Inpatients

(2012) Ahikam Olmer et al.   JOURNAL OF NERVOUS AND MENTAL DISEASE

Additional data on citalopram and the risk of sudden cardiac death and ventricular arrhythmia

(2012) Charles E. Leonard et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Reconciling the risk of QT interval prolongation in antidepressants

(2012) A. J. Mckean et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Assessing QT Interval Prolongation and its Associated Risks with Antipsychotics

(2011) Jimmi Nielsen et al.   CNS DRUGS

The effect of sertindole on QTD and TPTE

(2010) J. Nielsen et al.   ACTA PSYCHIATRICA SCANDINAVICA

QTc Intervals in Drug Poisoning Patients with Tricyclic Antidepressants and Selective Serotonin Reuptake Inhibitors

(2010) Ayça Açikalin et al.   AMERICAN JOURNAL OF THERAPEUTICS

National Trends in Psychotropic Medication Polypharmacy in Office-Based Psychiatry

(2010) Ramin Mojtabai et al.   ARCHIVES OF GENERAL PSYCHIATRY

Block of the human ether-a-go-go-related gene (hERG) K+ channel by the antidepressant desipramine

(2010) Hee-Kyung Hong et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Evaluation of a QT nomogram for risk assessment after antidepressant overdose

(2010) W. Stephen Waring et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Toxicity of antidepressants: rates of suicide relative to prescribing and non-fatal overdose

(2010) Keith Hawton et al.   BRITISH JOURNAL OF PSYCHIATRY

hERG K+ channel-associated cardiac effects of the antidepressant drug desipramine

(2010) Ingo Staudacher et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Torsade de Pointes Episodes under Treatment with Selective Serotonin Reuptake Inhibitors

(2010) K. Wenzel-Seifert et al.   PHARMACOPSYCHIATRY

Proarrhythmic Risk with Antipsychotic and Antidepressant Drugs

(2009) W. Victor R. Vieweg et al.   DRUGS & AGING

Sertindole causes distinct electrocardiographic T-wave morphology changes

(2009) Jimmi Nielsen et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

A comparative study of non-fatal self-poisoning with antidepressants relative to prescribing in three centres in England

(2009) Helen Bergen et al.   JOURNAL OF AFFECTIVE DISORDERS

Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines

(2008) IM Anderson et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Drug-induced torsades de pointes: a review of the Swedish pharmacovigilance database

(2008) Cecilia Åström-Lilja et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY